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Plasmacytoid dendritic cells (PDC), the natural type-1 interferon (IFN) producing cells, are part of the innate immune defense against
human immunodeficiency virus (HIV). PDC numbers are reduced in advanced stages of infection. These cells can be infected in vivo by HIV
since highly purified PDC showed evidence of infectious HIV. Moreover, when PDC derived from uninfected donors were exposed to high-
titered HIV isolates, productive infection occurred although with low-level replication. Using real-time amplification, PDC and unstimulated
CD4+ cells were found equally susceptible to HIV infection; however, HIV replication was considerably limited in the PDC. Virus replication
was enhanced after PDC treatment with CD40L and antibodies against IFN-a, most likely reflecting the reduction in IFN-a activity. On
maturation, the infected PDC showed multinuclear cell syncytia formation and death. These findings indicate that PDC can be reservoirs for
HIV dissemination and that HIV infection of PDC can contribute to their decline.
D 2004 Elsevier Inc. All rights reserved.
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Two distinct subpopulations of circulating dendritic cells
have been identified depending on their cellular phenotype:
myeloid-derived dendritic cells (mDC) and lymphoid-
derived dendritic cells (Liu, 2001). The latter cells, termed
natural interferon-a-producing cells (Fitzgerald-Bocarsly,
1993), are now called plasmacytoid dendritic cells (PDC)
and have been identified as the major producers of type 1
interferons (IFN) (Cella et al., 1999; Siegal et al., 1999).
Addition of interleukin (IL-)3 and CD40 ligand (CD40L)
results in their differentiation into dendritic cells (DC-2)0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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cytes to produce IL-4, IL-5, and IL-10, and directing the
immune response into a T-helper (TH)-2 phenotype (Kado-
waki et al., 2000; Rissoan et al., 1999). Upon response to
viral pathogens, PDC maturation also promotes naRve CD4+
cells to produce IFN-g and IL-12, driving a potent TH-1
polarization (Cella et al., 2000). These observations link
innate and adaptive immunity (Kadowaki et al., 2000;
Rissoan et al., 1999).
In HIV-infected patients, a decline in PDC has been
shown to correlate directly with the clinical stage of disease
and to be inversely associated with plasma HIV viral load
(Barron et al., 2003; Chehimi et al., 2002; Feldman et al.,
2001; Soumelis et al., 2001). This correlation has similarly
been observed after HIV primary infection (Pacanowski
et al., 2001), suggesting an important role of PDC in
controlling HIV replication in infected individuals. PDC
express high levels of surface CD4 (Grouard et al., 1997) as04) 280–288
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et al., 2002; Patterson et al., 2001; Yonezawa et al., 2003).
These cells, therefore, should be targets for HIV infection.
Early reports suggested that PDC are highly susceptible
to HIV infection (Patterson et al., 1999, 2001). However, the
purity of the isolated cell population obtained by negative
selection was not verified, and the extent of virus infection
and replication were not well quantified. In recent studies,
using positively selected cells with increased purity, PDC
were found to frequently harbor provirus in vivo, compa-
rable to CD4+ cells (Donaghy et al., 2003). Other reports
failed to detect efficient HIV replication in highly purified
PDC, unless the cells were matured by CD40L (Fong et al.,
2002). Another study noted only low-level virus replication
in PDC by p24 antigen determination, which was about 10-
fold less than that observed with myeloid dendritic cells
infected in parallel (Yonezawa et al., 2003). Finally, other
approaches have failed to detect proviral DNA and to isolate
virus from PDC and MDC of HIV-infected patients on
virally suppressive antiretroviral therapy, suggesting that
PDC are not a major HIV-1 reservoir (Otero et al., 2003).
Using positively selected highly purified PDC, our
studies addressed three important aspects of HIV infection
of PDC: (i) to compare the extent of PDC vs. CD4+ cell
infection by HIV in vivo and in vitro; (ii) to elucidate the
effect of PDC maturation and HIV replication on IFN-a
production; and (iii) to determine the effect of HIV infection
on PDC morphology and viability before and after matura-
tion of the cells.Fig. 1. In vivo and in vitro infection of plasmacytoid dendritic cells (PDC).
(a) Isolation of virus from highly purified PDC and CD4+ T cells of an HIV-
infected individual, obtained after coculture with phytohemagglutinin
(PHA)-stimulated CD4+ T cells from an HIV-negative donor. Half of the
PDC had been stimulated with CD40 ligand (CD40L) for 1 day before
coculture with the CD4+ cells. Reverse transcriptase (RT) activity was
determined in the culture fluids (Hoffman et al., 1985) after days (D) 2, 4, 6,
and 8. (b) Comparison of viral replication in highly purified PDC and PHA-
stimulated CD4+ cells, obtained from an uninfected donor and inoculated
with high-titered HIV-1SF33 (MOI 0.1). Infected cells were trypsinized 2 h
after virus inoculation to remove input virus. Results are representative of
studies with three different donors. (c) Recovery of virus from the HIV-1SF33-
infected PDC or CD4+ cells (see experiment 1b), after PHA-stimulated
CD4+ cells from an uninfected donor were added at day 6 (D6) post
inoculation (p.i.). Similar results were obtained from studies with three
different donors.Results
HIV infection of peripheral blood PDC in vivo
To determine whether PDC circulating in the blood of
HIV-infected individuals are directly infected with HIV, four
different subjects were studied. Infectious virus could be
isolated from highly purified PDC from one donor. This indi-
vidual consistently had a low CD4+ Tcell count (26 cells/Al),
but a high number of PDC (10.2 cells/Al) and a high viral load
(75000 RNA copies/ml). HIV was isolated from this highly
purified PDC population (N99%) after culture with CD40L
and IL-3 for 1 day followed by coculture of the PDC with
PHA-stimulated CD4+ Tcells from an uninfected donor (Fig.
1a). In parallel, PDC were cultured in IL-3 alone (Fig. 1a) or
cultured for several days in IL-3 and then treated with
CD40L. Addition of PHA-stimulated CD4+ cells from an
uninfected donor to the PDC cultured with IL-3 alone did not
release detectable virus as measured by reverse transcriptase
(RT) activity in the culture supernatant (Fig. 1a). These
findings indicate that virus was not merely attached to the cell
surface of PDC. The viral isolates from the PDC and CD4+
cells were sequenced in the V3 loop and the sequences were
found to be N98% identical (data not shown), suggesting that
PDC and CD4+ T cells are infected with similar viral strains.HIV infection of PDC in vitro
In these studies, we compared the sensitivity of highly
purified PDC and PHA-activated CD4+ cells to infection
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this virus showed no detectable virus replication as measured
by RT activity in the culture fluids (Fig. 1b). However, p24
antigen levels around 200 pg/ml in the culture supernatants
indicated low amounts of virus replication. When CD4+ T
cells were inoculated with the same virus input, high-level
HIV replication occurred within 2–4 days. To distinguish
frank virus infection of PDC from HIV attachment to these
cells with subsequent transfer to CD4+ Tcells, the PDC were
trypsinized 2 h after virus inoculation. After 4–6 days, these
cells showed the presence of virus replication when
cocultured with PHA-stimulated CD4+ T cells from unin-
fected donors (Fig. 1c).
This approach, however, did not exclude the potential
transfer of HIV to CD4+ cells via DC-SIGN or DC-SIGN-
R. When HIV interacts with DC-SIGN on dendritic cells,
virus can be internalized without leading to direct DC
infection (Kwon et al., 2002). One report noted expression
of DC-SIGN on a minor population of PDC (Soilleux et
al., 2002). However, as reported by others (Fong et al.,
2002), we found no evidence of either molecule on freshly
isolated PDC, the PDC cultured in IL-3 cells or those cells
cultured with IL-3 plus CD40L (data not shown). More-
over, when cell-free supernatants from HIV-1SF33 inocu-
lated PDC were transferred onto PHA-stimulated PBMC,
infectious virus could be recovered (Table 1). These
results support the conclusion that PDC can be infected
by HIV, but the efficiency of this infection appears to be
limited.
Comparison of the relative extent of HIV infection and
replication in PDC vs. primary CD4+ cells
To evaluate the reproducibility and linear range of the real-
time PCR, standard curves were generated for the house-
keeping gene protein kinase C (PKC, data not shown) and the
HIV-specific genes tat and gag (Figs. 2a,b). The suscepti-
bility of both cell types to HIV infection was then compared
using highly purified PDC and CD4+ cells obtained from
four different HIV-negative donors. Nonspecific tat and gagTable 1
HIV replication in PBMC inoculated with culture supernatants derived from HIV
Transfer of supernatant to PBMC at indicated day (D) R
D
D2 PDC 
PDC + HIV-1SF33 
CD4 + HIV-1SF33 +
D4 PDC 
PDC + HIV-1SF33 
CD4 + HIV-1SF33 +
D6 PDC 
PDC + HIV-1SF33 
CD4 + HIV-1SF33 +
Viral RT activity in culture fluids is represented as follows: below 10  103 cpm/m
cpm/ml (++). PBMC peripheral blood mononuclear cells, CD4 CD4+ T lymphocamplification for uninfected CD4+ cells did not occur before
threshold cycle 40. The X4 HIV-1SF33 added to PDC at an
MOI of 0.1 resulted in virus detection with mean threshold
cycles of 27.4 F 0.7 and 34.7 F 2.1 for tat and gag
amplification, respectively. At 12 h post-inoculation, the
relative ratios of specific to housekeeping gene were
compared for each cell type. The results showed the PDC
susceptibility to HIV infection was comparable to unstimu-
lated CD4+ cells and 10-fold less than the infectivity of PHA-
stimulated CD4+ cells (Fig. 2c).
The potential difference in HIV replication in the two
cell types was further analyzed by comparing 12-h vs. 4-
day-infected cells. In relation to housekeeping genes, a
3–4-fold increase in HIV presence in PDC was detected
vs. a 10-fold increase in HIV in unstimulated CD4+ cells
and a N20-fold increase in PHA-stimulated CD4+ cells
(Fig. 2d). At an MOI of 0.1, a relatively high percentage
of the PHA-stimulated CD4+ cells was already infected
12 h pi (Fig. 2c). Thus, the HIV replication could not be
fully quantified because the number of uninfected cells
required for exponential virus replication was limited.
Effect of maturation on HIV replication and IFN-a
production by PDC
After exposure to CD40L for 24 h, PDC maturation
was verified by expression of CD80, CD83, and CD86
(Fig. 3a). When PDC were cultured with CD40L
immediately after infection with high-titered HIV-1SF33,
viral replication was noted after 6 days (Fig. 3b). When
PDC were matured with CD40L for 24 h and then
inoculated with HIV, virus production was noted in 4
days. The kinetics of viral replication was confirmed by
the transfer of supernatants from the infected cells to
PHA-stimulated PBMC where infectious virus could be
detected (data not shown). CD40L similarly enhanced
viral replication in PDC inoculated with the R5 HIV-
1SF162 isolate as determined by a 3–5-fold increase in
p24 antigen production in two separate experiments (115
vs. 565 pg/ml at day 5; 224 vs. 664 pg/ml at day 9).-1SF33-infected PDC and CD4+ cells
T activity at indicated day
2 D4 D6 D8 D10
   
   
++ ++ ++ ++
   
  + +
++ ++ ++ ++
   
 + + +
+ + + ++
l (); between 10  103 and 100  103 cpm/ml (+); and above 100  103
ytes, PDC plasmacytoid dendritic cells. See also legend to Figs. 1b,c.
Fig. 2. Comparison of PDC vs. CD4+ cell susceptibility to HIV infection. Standard curves and linear ranges for real-time amplifications with tat (a) and gag (b)
primers, using serial dilutions of DNA extracted from HIVSF33-infected CD4+ cells. Data are representative of three separate experiments. The solid line is the
regression line, the dashed lines are 95% confidence intervals. (c) Ratios of specific (tat, gag) to housekeeping gene protein kinase C (PKC) for PDC and
CD4+ cells, infected for 12 h (inf. 12h). Cells were either used unstimulated (unstim.) or PHA-stimulated (stim.). Results were obtained by the 2CT-method
(Livak and Schmittgen, 2001) and are representative of four separate experiments with four different donors. Bars represent standard deviations. (d) Ratio of
specific (tat, gag) to housekeeping gene (PKC) for PDC and CD4+ cells, infected for 12 h (inf. 12h) or 4 days (inf. 4d). These data are representative of results
with two different donors.
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release and therefore HIV susceptibility, PDC were
cultivated with IL-3 and CD40L for 3 days before their
exposure to irradiated HSV. In the absence of CD40L,
the HSV-exposed PDC consistently released high amounts
of IFN-a (Fig. 3c). In contrast, maturation of PDC by
CD40L reduced this IFN-a release by 3-fold (3681 vs.
1164 pg/ml). These observations support the conclusion
that PDC maturation into DC-2 enhances HIV replication
most likely because of a reduction in interferon expres-
sion. This conclusion is supported further by our
observation that HIV replication by PDC was also
enhanced 3-fold when the cells were exposed to anti-
bodies to IFN-a (Fig. 3b).
Effect of HIV on PDC morphology and viability
When PDC were cultured in IL-3-containing medium,
they showed clustering within 24 h after plating. No
cytopathic effects were observed, however, in the unin-
fected, uninfected matured, and HIV-inoculated PDC over
the entire 8-day observation period (Fig. 3d, left panels).PDC viability was also unaffected by the HIV-1 inoculation,
as revealed by trypan blue staining after 8 days (Fig. 3d,
lower panel). However, after maturation with CD40L, the
virus-inoculated PDC developed multinuclear cell syncytia
and balloon degeneration (Fig. 3d, right panels) in
association with detectable levels of HIV replication. These
changes started 4 days after simultaneous exposure to
CD40L and HIV, and 1 day earlier if PDC had been
exposed to CD40L for 24 h and subsequently inoculated
with virus. (See also Fig. 3b.) Notably, these cytopathic
effects were also associated with clusters of dead cells.
Mechanism of PDC infection by HIV
To evaluate the role of the CD4 and CXCR4 receptors
in HIV infection, highly purified PDC (99.6%) were
inoculated in the presence of specific monoclonal anti-
bodies or the isotype (mouse IgG1) control antibody.
Antibodies were only present during HIV infection, and
the sodium azide concentration was adjusted for all
experiments. After virus inoculation, PDC were trypsi-
nized and then matured with CD40L. The CD4 and
Fig. 3. Effect of PDC maturation on viral replication, interferon induction, morphology, and cell viability. (a) PDC maturation after exposure to IL-3 (black
line) or IL-3 and CD40L (pink line) for 24 h, verified by CD83 expression on BDCA-4+ cells. Mean fluorescence intensity (MFI) was 108 vs. 247,
respectively. The percentage of BDCA4+, CD83+ cells increased from 11% to 50%. The effect on PDC activation, verified by CD80 and CD86 expression,
was less pronounced (data not shown). Results are representative of experiments with three different donors. (b) Reverse transcriptase (RT) activity in the
supernatants of highly purified PDC (99.2 %) and CD4+ T cells post inoculation (p.i.) with high-titered HIV-1SF33 (MOI 0.1) using different culture
conditions. PHA-stimulated CD4+ cells exposed to HIV plus CD40 ligand (CD40L) (!); PDC exposed to HIV plus CD40 ligand (5); PDC exposed to CD40
ligand for 1 day (1d) and then inoculated with HIV (n); PDC inoculated with HIV (o), and PDC inoculated with HIV and cultured in the presence of a
monoclonal antibody against IFN-a (anti-IFN-a) (4). No RT activity was detected in uninfected CD4+ cells and PDC (data not shown). PDC were freshly
isolated from uninfected volunteers. Results are representative of studies with two different donors. (c) IFN-a release by PDC after exposure to IL-3 or IL-3
plus CD40L for 3 days before exposure to HSV-1. Results are representative of three separate experiments. (d) Morphologic changes of highly purified PDC,
matured with CD40L (left panel), infected with HIV-1SF33 (middle left panel), matured and infected (D0) (middle right panel), or infected after maturation for
24 h (D1) (right panel). Viability staining with trypan blue was performed at 8 days post-virus inoculation (8d p.i.) (lower panel). Similar morphologic changes
were observed with PDC from another donor.
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the infection of CD4+ cells by 100% and 80%,
respectively. A comparable effect was observed with
PDC (Fig. 4), suggesting that the mechanism of infection
is similar to CD4+ cells.Discussion
Plasmacytoid dendritic cells could play a major role in
combating HIV infection (Levy, 2001). Why their number
decreases with advancement to disease is not yet known
(Soumelis et al., 2001). Early reports suggested that PDC
are highly susceptible to HIV infection in vitro (Patterson et
al., 1999, 2001) and thus could be killed by the virus.
However, the PDC purities in these studies may have beenaffected by the separation process of depleting lineage-
positive cells only (Robinson et al., 1999). Recently, HIV
infection of PDC in vivo has been noted following positive
selection of the cells with a purity of N95% (Donaghy et al.,
2003). However, the extent of virus replication in these cells
and any cytopathic effects were not reported.
In our experiments, we only used FACS-sorted PDC with
a purity of N99%, as has been used by others (Fong et al.,
2002; Yonezawa et al., 2003). Our studies confirm that PDC
are susceptible to HIV infection in vivo and in vitro, as
shown by several experimental approaches. First, infectious
virus could be directly isolated from 130000 highly purified
PDC from an HIV-infected donor (Fig. 1a). The inability to
isolate HIV from three other donors most likely reflects the
low number of highly purified PDC recovered (ranging
from 25000 to 55000 cells). Second, virus could be
Fig. 4. Effects of antibodies to CD4 (Leu3a) and CXCR4 on HIV-1SF33
infection of PDC. Results are presented as reverse transcriptase (RT)
activity in the supernatants of the infected cells, 2–8 days post-inoculation
(p.i.). PDC were preincubated with anti-CD4 (5) and anti-CXCR4 ( R )
antibodies and the control antibody (mouse IgG1) ( S ) at 15 Ag/ml for 1 h
and then inoculated with HIV-1SF33 at an MOI of 0.1. A control culture
received no antibody (n). After 2 h p.i., the antibodies were washed out;
PDC were trypsinized and then matured by CD40L. The extent of virus
replication was measured by reverse transcriptase (RT) activity in the
culture fluids.
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PHA-stimulated CD4+ cells, after any adherent virus was
removed by trypsinization (Fig. 1c; Table 1). Third, real-
time amplification of proviral DNA in PDC vs. unstimulated
CD4+ cells indicated a similar susceptibility of both cell
types to HIV infection (Fig. 2), which supports findings by
others (Donaghy et al., 2003). A major difference in our
studies is the low-level replication of HIV in PDC vs. CD4+
cells and the absence of any cytopathic effects in the
infected PDC not exposed to CD4OL (Fig. 3d).
PDC were productively infected by both X4 and R5
viruses. However, low-level virus replication could only be
detected by p24 antigen determination rather than virus
particle-associated RT activity, which has a lower sensitivity.
These findings were supported by the real-time PCR results
showing only a 3–4-fold increase in proviral DNA in PDC
over 4 days, which was considerably lower than that
observed for unstimulated and, in particular, stimulated
CD4+ cells (Fig. 2). The observations suggest that the
distinction in the level of HIV infection between PDC and
CD4+ cells is primarily due to a difference in HIV
replicative capacity in the cells.
The lowHIV production by PDC could be explained by an
effect of type 1 interferons. Maturation with CD40L
enhanced viral replication by infected PDC by 3–5-fold, as
reported by others (Fong et al., 2002) (Fig. 3b). With PDC
maturation, the induction of interferon production is
decreased substantially (Fig. 3c). Moreover, as observed by
others (Yonezawa et al., 2003), HIV replication was also
enhanced by antibodies against IFN-a (Fig. 3b). Importantly,
under the conditions of PDC maturation, the HIV-inoculated
cells developed giant multinuclear cell syncytia and died
(Fig. 3d) very similar to the cytopathic effects observed in the
lymph nodes of HIV-infected patients (Fong et al., 2002).These changes were only observed if PDCwere isolated from
blood drawn at the same day, and if virus was pelleted before
PDC inoculation to avoid any cytokine contamination. This
approach may explain why these findings have not been
reported by others.
The level of PDC in HIV-infected individuals reflects
directly the CD4+ cell count and inversely the viral load
(Soumelis et al., 2001). Low PDC numbers are associated
with the appearance of opportunistic infections and Kaposi’s
sarcoma (Soumelis et al., 2001). The reason for a decline in
circulating PDC in advanced stages of disease is not known
but could reflect direct HIV infection of these cells and their
maturation as well as migration of the PDC to lymphoid
tissues. Our data indicate that HIV infection of PDC takes
place but viability of the PDC and their phenotype are not
affected (Fig. 3d). Cell death occurs only after substantial
viral replication takes place when the PDC have contact
with activated CD4+ cells providing CD40 ligand for PDC
maturation (Fig. 3d).
In AIDS patients, the immune system can be activated by
stimuli such as viral and bacterial opportunistic infections
providing bacteria-derived ligands of Toll-like receptor
family members (Hemmi et al., 2000; Kadowaki et al.,
2001). This process could increase the frequency of
stimulated CD4+ cells expressing CD40 ligand that could
interact with PDC. Thus, maturation of the PDC and their
transit from the peripheral blood to lymphoid tissues would
be increased (Cyster, 1999). In addition, the matured PDC
will show enhanced viral replication, cytopathic effects, and
cell death. These events could explain the loss of circulating
PDC numbers and function in HIV infection. Finally,
infected PDC can be a source for spread of HIV, when
they respond to different stimuli and migrate to secondary
lymphatic tissue (Cella et al., 1999).
Current studies are directed at understanding further the
mechanism of PDC depletion and how PDC numbers could
be increased in the infected host to prevent opportunistic
infections and malignancies in HIV-infected individuals
(Arpinati et al., 2000; Chen et al., 2004; Maraskovsky et al.,
2000).Materials and methods
Isolation of PDC and CD4+ cells
Using Ficoll-Hypaque separation (Sigma Diagnostics
Inc., St. Louis, MO), peripheral blood mononuclear cells
(PBMC) were obtained from EDTA-containing blood of
uninfected volunteers or from buffy coat bags provided by
the Blood Centers of the Pacific (San Francisco, CA). PDC
were then purified from the PBMC population by staining
with anti-BDCA4-PE (Dzionek et al., 2000) and anti-PE
MicroBeads (Miltenyi Biotec, Auburn, CA), followed by
one-column separation using a MACS MS column (Milte-
nyi Biotec). PDC were subsequently counterstained with
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FACSVantage Cell Sorter (BD Biosciences, San Jose, CA),
available at the SFGH Immunology Core facility. Purity of
the sorted PDC was confirmed by staining an aliquot of
these cells using either FITC-conjugated BDCA-2 anti-
bodies (Miltenyi Biotec) or a FITC-conjugated lineage
cocktail consisting of mouse monoclonal antibodies to
human CD3, CD14, CD16, CD20, and CD56. After sorting,
PDC were highly pure (N99%), as measured on a FACSort
with CellQuest Software (BD Biosciences). CD4+ T cells
were isolated from the separated PBMC using CD4
MicroBeads (Miltenyi Biotec) by standard procedures.
Isolated cells were cultivated in RPMI 1640 medium
containing 10% heat-inactivated (56 8C, 30 min) fetal
bovine serum, 2 mM glutamine, 100 U/ml penicillin, and
100 Ag/ml streptomycin, supplemented with 20 ng/ml IL-3
(R&D Systems, Minneapolis, MN) or 20 U/ml (10 ng/ml)
human IL-2 (Roche Diagnostics, Indianapolis, IN) for PDC
and CD4+ cells, respectively. PDC were matured by CD40L
(received from Immunex Corp., Seattle, WA) at a final
concentration of 0.5 Ag/ml. Typically, from a buffy coast of
500  106 cells, we recovered 5  105 PDC.
Virus stocks
PDC were infected with HIV-1SF33, a CXCR4-tropic
syncytium-inducing (SI) chemokine-insensitive isolate
(Tateno and Levy, 1988), and the CCR5-tropic non-syncy-
tium-inducing (NSI) isolate HIV-1SF162 (Cheng-Mayer et al.,
1989). Virus stocks were generated by infecting PHA-
stimulated CD4+ cells or PBMC, then adding PBMC when
high viral production occurred as measured by reverse
transcriptase (RT) activity in the culture fluids (Hoffman et
al., 1985). The supernatants were harvested at peak viral
replication, which usually occurred within 2–3 days of
passage. The TCID50 was quantified in PBMC stimulated
by PHA and IL-2 (McDougal et al., 1985).
Infection of PDC and CD4+ T cells
Before infection, CD4+ cells were stimulated with 3 Ag/
ml of phytohemagglutinin (PHA) (Sigma) for 3 days,
washed, and then pretreated for 30 min with 2 Ag/ml of
polybrene (Sigma). The PDC and CD4+ cells were infected
in parallel with viral stocks (see above) at a multiplicity of
infection (MOI) of 0.1. To avoid cytokine contamination,
viruses were pelleted at 12000 rpm for 1–2 h before use. To
remove viral particles adherent to the cell surface, the cells
were treated with 0.15% trypsin (Tang and Levy, 1991) 2 h
after virus inoculation.
PDC were plated at a density of 0.5  105 to 1  105
cells/well in 96-well flat bottom plates. Virus replication
was assessed by measuring RT activity in the culture fluids
(Hoffman et al., 1985). Low amounts of virus replication
were monitored by p24 antigen ELISA (Immunotech, West
Brook, ME). The presence of infectious virus was detectedby transfer of cell-free supernatants (100 Al) to PHA-
stimulated PBMC (105 cells/well) obtained from uninfected
donors. Virus transfer from 6d-infected trypsinized PDC
was evaluated by adding PHA-stimulated CD4+ cells (105
cells/well) to the culture and measuring RT activity in the
culture fluids.
Biologic reagents
The neutralizing antiserum to IFN-a antibody was
obtained from the NIAID Research Resources (Cat. No.
G026-501-568). Antibodies to CD4 (SK3) were obtained
from Becton Dickinson (San Jose, CA). The CXCR4
antibody (2G12) was kindly provided by Jim Hoxie
(Philadelphia, PA). The isotype control antibody (mouse
IgG1) came from BD PharMingen (San Diego, CA).
Antibodies were generally used at 15 Ag/ml, by preincubat-
ing PDC or CD4+ cells at 37 8C for 60 min before virus
inoculation. Sodium azide was purchased from Sigma.
Monoclonal antibodies for FACS analysis were obtained
from Miltenyi Biotec (BDCA-4), BD Biosciences (CD4),
Immunotech, Coulter (Miami, FL) (CD83), and BD
PharMingen (CD80, CD86). Flow cytometry was per-
formed on a FACSort with CellQuest Software (BD
Biosciences).
IFN-a release assay
PDC were plated at 104 cells/well in a 96-well plate and
cultured in IL-3 or IL-4 plus CD40L for 3 days. Super-
natants were harvested 48 h after PDC exposure to HSV-1
attenuated by UV irradiation at a final concentration of 106
PFU/ml (kindly provided by Yong-Jun Liu, Palo Alto, CA).
The IFN-a activity was assayed using a sandwich enzyme
linked immunosorbent assay (ELISA) (Biosource Interna-
tional, Camarillo, CA) according to the manufacturer’s
instructions. All samples were evaluated in duplicate and
diluted if appropriate.
Real-time quantitative PCR
DNA extraction
DNA was extracted from at least 4  105 PDC and
CD4+ cells, plated in 48-well flat bottom plates and
harvested 12 h and 4 days after virus inoculation. The
extraction was performed using the QIAamp DNA Mini Kit
(Qiagen, Valencia, CA) according to the manufacturer’s
instructions. The DNA concentration was determined using
the spectrometer.
Primers: F, forward; R, reverse
HIV-specific genes tat and gag were amplified using the
oligonucleotides HIV-TAT-F (5V-CCT-AAC-CTA-GAG-
CCC-TGG-AA-3V) plus HIV-TAT-R (5V-TTC-CTG-CCA-
TAG-GAT-ATG-CCT-AA-3V), and SF2-p24-F (5V-TCA-
ATG-AGG-AAG-CTG-CAG-AA-3V) plus SF2-p24-R (5V-
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housekeeping gene protein kinase C (PKC), expressed as
one gene per cell, was amplified using PKC-F (5V-CAA-
GGC-CAG-AGA-AGT-ATG-ATG-3V) plus PKC-R (5V-
GTG-GCA-GGG-AAG-GTC-TAG-GTA-G-3V). Virus-spe-
cific primers were able to detect many types of HIV-1 as
well as provirus from CD4+ T lymphocytes infected with
several patient virus isolates.
The standard curves for the housekeeping gene and
the HIV-specific genes were generated by amplification
of serial 10-fold dilutions of DNA extracted from
uninfected or HIV-infected CD4+ cells, respectively
(Victoria et al., 2003). The reproducibility was con-
firmed in three separate experiments.
Real-time amplification
Real-time PCR was performed using the GeneAmp 5700
Sequence Detection System (Applied Biosystems, Foster
City, CA). Each PCR reaction was performed in a 25-Al
reaction volume, using the 2 Sybr Green PCR Mastermix
(Applied Biosystems), supplemented by 200 nM of the
respective forward and reverse primer. A total of 20–50 ng
genomic DNA was loaded into each reaction. PCR
conditions were 95 8C for 10 min, followed by 50 cycles
of 95 8C for 15 s and 60 8C for 1 min. After amplification,
melting curve analysis was performed between 62 and 92 8C
to determine the Tm for specific and unspecific amplification
products. All amplifications were determined in triplicates
with a coefficient of variation of less than 30%. Each
separate experiment included genomic DNA extracted from
uninfected CD4+ cells as well as a water negative control.
Amplifications for PKC, tat, and gag were performed
simultaneously for each separate experiment.
Imaging
Light microscopic pictures were taken using an Olym-
pus OM-1 camera and digitalized by scanning slides with
Adobe Photoshop 6.
Statistical analysis of real-time results
Threshold cycles (CT) were determined from a log-linear
representation of the PCR signal vs. the cycle number, thus
representing exponential, not linear data. Therefore, relative
ratios between HIV-specific and housekeeping gene were
determined using the 2CT-method (Livak and Schmittgen,
2001). Values for gag/PKC were multiplied by 100 to adjust
for the considerably lower amplification efficiency com-
pared to tat.Acknowledgments
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